EcoDrugPlus

Prostaglandin E Receptor 3

Ensembl ID : ENSDORG00000016347
Gene Symbol: PTGER3
4 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSDORG00000005762
Gene Symbol: PTGER4
4 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSDORG00000025401
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSDORG00000005401
Gene Symbol: PTGIR
4 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSDORG00000015866
Gene Symbol: PTGS1
4 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSDORG00000002998
Gene Symbol: PTGS2
4 Cross references
240 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 2

Ensembl ID : ENSDORG00000027956
Gene Symbol: PSMB2
1 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSDORG00000009494
Gene Symbol: PSMA1
3 Cross references
236 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSDORG00000011746
Gene Symbol: PSMA2
4 Cross references
231 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSDORG00000002167
Gene Symbol: PSMA3
2 Cross references
245 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSDORG00000001563
Gene Symbol: PSMA4
4 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSDORG00000004037
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).